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ROLE OF HYDROGEN SULFIDE (H2S)  IN CELL 
SIGNALING AND ATHEROSCLEROSIS: A REVIEW 
Mohd Izani Othman  
Faculty of Pharmacy, Universiti Teknologi MARA Cawangan Pulau Pinang, Kampus Bertam, 
Persiaran Pendidikan Bertam Perdana, 13200 Kepala Batas, Pulau Pinang, MALAYSIA. 
mohdizani.othman@ppinang.uitm.edu.my 
ABSTRACT 
Hydrogen sulfide (H2S) has been known for decades as a toxic gas. However, 
this gas has been discovered to be synthesised enzymatically in human tissues 
and is regarded as a novel gasotransmitter. H2S is a signaling molecule that 
involves and governs many biological functions of the body. It has been shown 
that H2S is associated with various disease conditions such as acute 
pancreatitis, sepsis, inflammation and atherosclerosis development. Current 
therapeutic approach may not benefit all patients with atherosclerosis. 
Therefore, the role of H2S as an anti-atherosclerotic agent has been the 
spotlight of cardiovascular medicine. Moreover, its implications in other 
diseases have also been studied extensively in order to develop new therapeutic 
approaches. 
Keywords: hydrogen sulfide (H2S); atherosclerosis; reactive oxygen species (ROS); 
signaling molecule; oxidative stress; oxidised low density lipoprotein (oxLDL).  
1. INTRODUCTION 
 Hydrogen sulfide (H2S) is a colourless, flammable and poisonous gas with a characteristic 
rotten egg odour. This gas is present in the effluent of hydrothermal vents and sulphur springs 
and has long been known as a toxic pollutant (Mancardi et al., 2009). Interestingly, H2S has 
been recognised as an important signalling molecule of the cardiovascular, inflammatory and 
immune systems (Wagner et al., 2009). It plays a vital role as a novel biologically active gas 
alongside with nitric oxide (NO) and carbon monoxide (CO) which involves in intracellular 
signalling processes (Song et al., 2014).  
An increasing body of evidence has implicated the involvement of H2S in biological systems 
through a variety of interrelated mechanisms (Szabo, 2007). In the past decade, H2S has 
emerged as an important mediator in various physiological and pathophysiological processes 
(Whiteman et al., 2011). Studies have shown that H2S can either protect or damage cells and 
this depends on its concentration, types of cell as well as experimental conditions (Wagner et 
al., 2009). High levels of H2S are always accompanied by cytotoxic effects that could result 
from free radical generation and loss of glutathione (GSH). Low levels of H2S have been 
shown to be either cytoprotective or proapoptotic (Adhikari & Bhatia, 2008).  
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1.1 Biosynthesis and metabolism of H2S 
H2S is enzymatically synthesised from amino acid cysteine, homocysteine and cystathionine 
by pyridoxal-5’-phosphate (PLP)-dependent enzymes such as cystathionine-β-synthase (CBS; 
E.C. 4.2.1.22) and cystathionine-γ-lyase (CSE; E.C. 4.4.1.1) (Whiteman et al., 2011). CBS 
and CSE are expressed in various locations including the brain, peripheral nervous system, 
liver, joint cells, intrauterine tissue, placenta and kidney (Whiteman et al., 2011).  However, 
CBS is predominantly expressed in the brain and nervous system (Kimura, 2000) while CSE 
is mainly observed in vascular smooth muscle cells and in the heart (Zhao et al., 2001). It has 
also been proposed that 3-mercaptopyruvate sulfurtransferase (3-MST) which is an α-
ketoglutarate and cysteine-dependent enzyme located in mitochondria (Shibuya et al., 2009) 
generates H2S within the mitochondria (Modis et al., 2013a). 3-MST is also expressed in the 
brain and most of the H2S produced by this enzyme is bound to the form of sulfane sulphur. 
In vivo, H2S is metabolised by oxidation in mitochondria or by methylation in cytosol and can 
be scavenged by methemoglobin or by metallo- or disulfide-containing molecules such as 
oxidised glutathione (Wang, 2003). H2S is mainly excreted in the kidney as free or conjugated 
sulfate and as thiosulfate (Wang, 2003) and is also exhaled from the lungs.  
1.2 Physiological and Pathophysiological Roles of H2S 
Various physiological effects of H2S include as a major endothelium-derived hyperpolarising 
factor (EDHF) which causes hyperpolarisation and vasorelaxation of vascular endothelium 
and smooth muscle cells (Yang et al., 2008). As an antioxidant, H2S can also prevent cytokine 
or oxidant-induced oxidative damage (Taniguchi et al., 2011). Moreover, H2S can also down-
regulate NF-κB activation or up-regulate heme oxygenase 1 expression, thus inhibiting the 
expression of pro-inflammatory factors (Pan et al., 2011).  
Pathophysiological role of H2S has been implicated in many inflammatory and cardiovascular 
diseases (Bhatia, 2012).  H2S has been demonstrated to protect against oxidative injury in in 
vivo and in vitro models of myocardial ischemia-reperfusion models (Chen et al., 2007). 
Moreover, the inhibition of H2S synthesis has been shown to accelerate the recovery of mean 
arterial pressure in a haemorrhagic shock model (Mok et al., 2004). Other beneficial effect of 
lowering H2S levels was demonstrated in carrageenan-induced hindpaw edema (Bhatia et al., 
2005b) and acute pancreatitis (Bhatia et al., 2005a). 
1.3 H2S as Reactive Oxygen Species (ROS) Scavenger and Inhibitor 
H2S is capable of scavenging free radicals by single electron or hydrogen atom transfer 
(Carballal et al., 2011). H2S has been reported to scavenge reactive oxygen and nitrogen 
species such as superoxide (Yan et al., 2006), hydrogen peroxide (Lu et al., 2008), 
peroxynitrate (Whiteman et al., 2004), hypochlorous acid (Whiteman et al., 2005) and lipid 
hydroperoxides (Carballal et al., 2011).  
In human endothelial cells (Muzaffar et al., 2008a) and vascular smooth muscle cells 
(Muzaffar et al., 2008b), H2S has been demonstrated to inhibit superoxide production by 
reducing NADPH oxidase (NOX) expression and activity. Samhan-Arias et al. (2009) have 
also shown that H2S protects synaptic plasma membranes from oxidative stress by the 
inhibition of ROS production via NOX.  
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1.4 Roles of H2S in the Mitochondria 
Mitochondrion plays a vital role as the key source and target for detrimental intracellular 
oxidants generation (Murphy, 2009). Studies have implicated the importance of H2S in 
regulating mitochondrial function (Modis et al., 2013a) as well as reducing mitochondrial 
ROS generation (Sun et al., 2012). Recent studies by Modis et al. (2013a) demonstrated that 
low levels of H2S generated by mitochondrial enzyme, 3-MST, has donated electrons to the 
Krebs cycle, enhancing mitochondrial electron transport and bioenergetics. In hepatoma cells, 
this effect is suppressed during oxidative stress but reversed with administration of exogenous 
H2S (Modis et al., 2013b). 
In addition, translocation of CBS (Fu et al., 2012) and CSE (Modis et al., 2013b) from the 
cytosol to the mitochondrial matrix in response to hypoxic and calcium stress have also been 
observed. The resulting H2S generation within the mitochondria might act as an electron 
acceptor in the mitochondrial respiratory chain which then increases cellular ATP production, 
thus preserving cell viability (Fu et al., 2012; Modis et al., 2013b). 
1.5 H2S Involvements in Intracellular Calcium Regulation 
Calcium (Ca2+) plays an important role as key signalling molecule in regulating various 
biological processes. Cytoplasmic concentration of Ca2+ is being tightly regulated within 
nanomolar range, which is approximately ten thousand fold difference across plasma 
membrane (1.5 mM at extracellular and 0.1 µM in cytosol) (Montell, 2005). Extracellular 
Ca2+ can cross plasma membrane via two major pathways i.e. voltage-operated Ca2+ channels 
(VOCCs) and receptor operated Ca2+ channels (ROCCs) (Pinilla et al., 2005). Studies have 
demonstrated that H2S has the capability of either inhibiting or activating Ca2+ entry and this 
depends on the molecular nature of the Ca2+ entry pathway [reviewed by Munaron et al. 
(2013)]. 
In exerting cardioprotective effect, it has been proposed that H2S causes indirect inhibitory 
action on L-type calcium channels (VOCCs) besides directly inhibiting the β-adrenergic 
receptors (Mancardi et al., 2009). Thus, Sun et al. (2008) have shown the ability of H2S to 
inhibit L-type calcium channels in NaHS treated rat cardiomyocytes whereas Maeda et al. 
(2009) have reported that H2S may facilitate membrane currents through T-type calcium 
channels. In studies done on endothelial cells, Bauer et al. (2010) concluded that H2S can 
directly regulate Ca2+ homeostasis and signalling via multiple mechanisms. 
1.6 Roles of H2S in Atherosclerosis 
Atherosclerosis is characterised by multiple key events including endothelial dysfunction, 
infiltration of monocytes into the vascular wall and their differentiation into macrophages, 
uptake of oxidised low density lipoprotein (oxLDL) and conversion of lipid laden 
macrophages into foam cells and smooth muscle cell proliferation. Increasing evidence has 
implicated the significant involvement of H2S in these biological processes and disruption of 
H2S homeostasis may contribute to the pathogenesis of atherosclerosis (Lynn & Austin, 
2011).  
Recent studies have suggested that macrophages are able to produce H2S endogenously (Zhu 
et al., 2010). Zhu et al. (2010) have reported the presence of CSE as well as endogenous H2S 
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production in peritoneal and RAW 264.7 macrophages treated with L-cysteine and PLP. They 
have also shown that lipopolysaccharide (LPS) stimulated CSE but not CBS expression and 
H2S generation in macrophages.  
Laggner et al. (2007) demonstrated that H2S counteracts LDL oxidation by HOCl, whereby 50 
µM HOCl was completely scavenged in the presence of equimolar concentrations of NaHS 
for 30 min at 37oC. In addition to its HOCl scavenging potential, the authors also found that 
H2S inhibited myeloperoxidase (MPO) activity and scavenge H2O2. Studies done on HMDM 
cells by Zhao et al. (2011) revealed that NaHS treatment significantly suppressed macrophage 
derived foam cell formation by inhibiting oxLDL binding and uptake into macrophages. In 
addition, NaHS treatment significantly lowered the levels of CD36, scavenger receptor A and 
acetyl co-enzyme A acyltransferase-1 (ACAT1) expressions which were up-regulated by 
oxLDL in HMDM cells via KATP/ERK1/2 pathway.  
1.7 H2S Donors 
Recently, several H2S releasing molecules (termed as H2S donors) have been developed to 
deliver a controlled and stable delivery of H2S to cells and tissues. The development and 
characterisation of appropriate H2S donors are vital for pharmacological use. H2S donors 
should not be toxic, should be soluble in aqueous media, should not metabolise rapidly and 
should release H2S in vivo slowly (Whiteman et al., 2011).  
Although sulfide salts such as NaSH or Na2S (Szabo, 2007) can be conveniently used to 
prepare standardised H2S solution, they are not useful to be studied in H2S physiology. This is 
because generation of both H2S and Na+ as an instantaneous release of bolus dissipates in a 
very short period of time (Li et al., 2008) rather than replicate the slow and sustained 
generation of H2S from CSE, CBS or 3-MST enzymes in the tissues. Additionally, a huge and 
quick release of H2S result in rapid fall of blood pressure which may have damaging effects in 
tissues or organs (Li et al., 2008). 
Theferore, organic H2S donors which generate H2S in a physiologically-like manner were 
developed and synthesised (Whiteman et al., 2011) to avoid the use of sulfide salts. Existing 
non-steroidal anti-inflammatory drugs (NSAIDs) compounds such as indomethacin (ATB-
343), diclofenac (ACS-15), naproxen (ATB-345) and mesalamine (ATB-429) (Whiteman & 
Winyard, 2011) have been modified by adding ADT-OH [5-(4-hydroxyphenyl-3H-1,2-
dithiole-3-thione] group. Studies have shown that these organic H2S donors actively alleviate 
and limit the adverse effects and toxicity of NSAIDs and demonstrate promising outcomes in 
treating inflammatory bowel disease, oedema, acute inflammation and endotoxic shock. Even 
though the precise mechanism of how ADT-OH releases H2S is unknown (Whiteman et al., 
2011), the potential therapeutic effects of ADT-OH derivatives in treating inflammatory and 
vascular disease as well as cancer is at least partly due to the release of H2S (Whiteman et al., 
2011). 
The more recently synthesised and characterised H2S donors do not consist of structurally 
modified established drug molecules such as GYY4137 (Whiteman et al., 2011). These water-
soluble novel H2S donors provide as pharmacological tools which generate H2S at different 
rates. Recently, a novel dithiolethione derivative containing a triphenylphosphonium moiety 
(AP39) enabling specific delivery of sub-nanomolar concentrations of the compounds to 
mitochondria was also developed (Le Trionnaire et al., 2014).  
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In recent years, there has been a significant development in the H2S studies, particularly in 
health and disease. However, most of the studies on H2S potentials have used sulfide salts. 
This might not be the best because of the rapid release of H2S due to their high water 
solubility resulting in high local concentrations and lack of sustained effects. In contrast, slow 
releasing H2S donors offer more reliable data regarding physiological effects of H2S and 
provide  potential opportunity for drug discovery including as possible candidates for treating 
atherosclerosis. 
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